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Abstract

Introduction The hemochorial placenta provides a
critical barrier at the maternal–fetal interface to modulate
maternal immune tolerance and enable gas and nutrient
exchange between mother and conceptus. Pregnancy
outcomes are adversely affected by diabetes mellitus;
however, the effects of poorly controlled diabetes on
placental formation, and subsequently fetal development,
are not fully understood.
Research design and methods Streptozotocin was
used to induce hyperglycemia in pregnant rats for the
purpose of investigating the impact of poorly controlled
diabetes on placental formation and fetal development.
The experimental paradigm of hypoxia exposure in
the pregnant rat was also used to assess properties of
placental plasticity. Euglycemic and hyperglycemic rats
were exposed to ambient conditions (~21% oxygen) or
hypoxia (10.5% oxygen) beginning on gestation day (gd)
6.5 and sacrificed on gd 13.5. To determine whether the
interaction of hyperglycemia and hypoxia was directly
altering trophoblast lineage development, rat trophoblast
stem (TS) cells were cultured in high glucose (25 mM) and/
or exposed to low oxygen (0.5% to 1.5%).
Results Diabetes caused placentomegaly and placental
malformation, decreasing placental efficiency and fetal
size. Elevated glucose disrupted rat TS cell differentiation
in vitro. Evidence of altered trophoblast differentiation
was also observed in vivo, as hyperglycemia affected
the junctional zone transcriptome and interfered with
intrauterine trophoblast invasion and uterine spiral artery
remodeling. When exposed to hypoxia, hyperglycemic rats
showed decreased proliferation and ectoplacental cone
development on gd 9.5 and complete pregnancy loss by
gd 13.5. Furthermore, elevated glucose concentrations
inhibited TS cell responses to hypoxia in vitro.
Conclusions Overall, these results indicate that
alterations in placental development, efficiency, and
plasticity could contribute to the suboptimal fetal outcomes
in offspring from pregnancies complicated by poorly
controlled diabetes.

Introduction
The impact of diabetes on pregnancy
outcomes has become an increasing health
concern.1 During pregnancy maternal
glucose can cross the placenta, which results
in fetal exposure to hyperglycemia during
critical stages of intrauterine development.2

Significance of this study
What is already known about this subject?
►► Pregnancy outcomes are adversely affected by dia-

betes mellitus.
►► Successful pregnancy in the human requires deep

trophoblast cell invasion and extensive spiral artery
remodeling to facilitate optimal maternal blood delivery to the developing conceptus.

What are the new findings?
►► Diabetes-induced placental malformation decreases

placental efficiency and fetal size.
►► Hyperglycemia disrupts rat trophoblast stem cell dif-

ferentiation into invasive trophoblast.
►► Diabetes impairs intrauterine trophoblast invasion.
►► Hyperglycemia adversely affects placental adapta-

tions to hypoxia.
►► High glucose blunts trophoblast stem cell responses

to low oxygen.

How might these results change the focus of
research or clinical practice?
►► Investigating placental development in the context

of disease is imperative to the discovery of future
preventative and therapeutic strategies.

Increasing evidence supports the idea that
pregnancy complications and poor fetal
outcomes associated with diabetes could be
linked to defects in placental development
and function.3 Successful pregnancy in the
human requires deep trophoblast cell invasion and extensive spiral artery remodeling to
facilitate optimal maternal blood delivery to
the developing conceptus.4 5 Numerous physiological and environmental factors can affect
trophoblast cell development and, thus, the
extent of trophoblast cell-
mediated spiral
artery remodeling.6 7 Insufficient remodeling
can then lead to the development of severe
pregnancy complications. Thus, investigating
placental development in the context of
disease is imperative to the discovery of future
preventative and therapeutic strategies.
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Poorly controlled diabetes mellitus
alters placental structure, efficiency,
and plasticity

Pathophysiology/Complications

Research design and methods
Animal care and treatment specifications
Holtzman Sprague-Dawley rats were housed in an environmentally controlled facility at the University of Kansas
Medical Center (KUMC) with lights on from 0600 to
2000 hours and allowed free access to food and water.
Female rats (8–10 weeks of age) were mated with adult
male rats (>3 months of age). Mating was assessed by
inspection of vaginal lavages. The presence of sperm in
the vagina was designated gd 0.5. A single dose of either
STZ (45 mg/kg body weight) or vehicle control solution
(0.1 M citrate buffer, pH 4.2) was administered via tail
vein injection on gd 6.5 so as not to negatively impact
embryo implantation. In some experiments, STZ and
vehicle control-treated pregnant rats were placed in a
hypoxic (10.5% (vol/vol) oxygen) gas-regulated chamber
(BioSpherix, Lacona, New York, USA) from gd 6.5 to 9.5
or gd 6.5 to 13.5, which represent critical windows in
placental development. Pregnant rats housed in ambient
conditions (~21% (vol/vol) oxygen) served as controls.
Blood glucose measurements
Body weights and blood glucose were determined prior to
and after treatment to ensure equal dosage and hyperglycemia, respectively. Blood glucose levels were measured
from the tail vein using the OneTouch Ultra Smart blood
glucose monitoring system (LifeScan, Milpitas, California, USA).13
Tissue collection
Rat pancreas, spleen, liver, and placental tissues were
collected and weighed on gd 13.5 and gd 18.5. Entire
placentation sites, including the ectoplacental cone, were
dissected on gd 9.5. Placentation sites were dissected into
junctional zone, labyrinth zone, and metrial gland on gd
13.5 and 18.5, as previously described.14 Selection of gds
for analysis represented three critical stages of placentation: (1) the onset of placentation, gd 9.5, (2) establishment of placental zonation, gd 13.5, and (3) robust
2

infiltration of invasive trophoblast cells into the uterine
parenchyma, gd 18.5. Placentation sites were frozen in
dry-
ice cooled heptane for histological and morphometric analyses or dissected placentation site compartments snap-frozen in liquid nitrogen and stored at −80°C
until processing for biochemical analyses.
Rat trophoblast stem (TS) cell culture
Blastocyst-derived rat TS cells15 were cultured in basal
culture medium (RPMI 1640 (Cellgro), 20% fetal bovine
serum (Sigma-
Aldrich), 100 µM 2-
mercaptoethanol
(M7522; Sigma-Aldrich), 1 mM sodium pyruvate (ThermoFisher, 11 360–070), 50 µM penicillin (15140122;
ThermoFisher), and 50 U/mL streptomycin (15140122;
ThermoFisher)) supplemented with 70% rat embryonic
fibroblast-conditioned medium, fibroblast growth factor
4 (25 ng/mL; Sigma-
Aldrich), and heparin (1 µg/mL;
Sigma-Aldrich). To model hyperglycemia, 25 mM glucose
(Sigma-
Aldrich) was added to the culture medium.
mannitol (Sigma-
Aldrich) was added to the culture
D-
medium to control for osmolality. Rat TS cells were
exposed to ambient or low oxygen (0.5% or 1.5% O2)
tensions and 5% CO2 at 37°C in an NAPCO 8000 incubator (ThermoFisher) for 24 hours and then harvested
for immunocytochemical or biochemical analyses.
Immunohistochemistry and immunocytochemistry
Frozen placental tissues were sectioned at a thickness
of 10 µm with a cryostat. Immunohistochemical analysis was performed on placental sections by immunofluorescence detection using a pan-cytokeratin primary
antibody (1:250, F3418; Sigma-
Aldrich) and Alexa
488-
conjugated goat-
antimouse secondary antibody
(1:200, A11001; ThermoFisher). Nuclei were visualized
with 4’,6-
diamidino-2-
phenylindole (Molecular Probes,
Eugene, Oregon, USA). Rat TS cells were fixed with
4% paraformaldehyde (Sigma-
Aldrich) for 20 min at
room temperature. Immunocytochemical analysis was
performed by immunofluorescence detection using a
primary antibody against prolactin family 8, subfamily
A, member 5 (PRL8A5, 1:20016) followed by Alexa
568-conjugated goat-anti-rabbit secondary antibody
(1:200, A11001; ThermoFisher). Images were captured
on a Nikon 80i upright microscope (Nikon, Melville, New
York, USA) with a Photometrics CoolSNAP-
ES monochrome camera (Roper, Sarasota, Florida, USA).
Morphometric measurements
Depth and extent of invasion and size of placental
compartments were performed using ImageJ (National
Institutes of Health (NIH)) as previously described.17 18
Briefly, the depth of intrauterine trophoblast invasion
was quantified as an invasion index, defined as the
distance of distal-most cytokeratin-positive cell relative to
the trophoblast giant cell layer of the placenta divided by
the total distance from the giant cell layer to the outer
mesometrial uterine surface. The extent of intrauterine
trophoblast invasion was determined as the surface area
BMJ Open Diab Res Care 2020;8:e001243. doi:10.1136/bmjdrc-2020-001243
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In the current study, our goals were to investigate regulatory events mediating the deleterious effects of diabetes
on placental development and to evaluate the impact of
hyperglycemia on placental plasticity. To facilitate our
investigation, we administered streptozotocin (STZ)
to pregnant rats on gestation day (gd) 6.5 to induce
diabetes during pregnancy.8 STZ was first described as
a model of diabetes mellitus in 1976, due to its ability
to induce nearly complete beta cell destruction.9 STZ is
primarily considered a model of type 1 diabetes mellitus
because it targets and inactivates beta cells.10 STZ has
also been used in the context of pregnancy to study
the consequences of maternal glucose intolerance on
fetal outcomes.11 12 Using the STZ model, we show that
intrauterine exposure to hyperglycemia alters placental
morphology, efficiency, and plasticity. Thus, inadequate
placental function in mothers with poorly controlled
diabetes could contribute to poor fetal outcomes.

Pathophysiology/Complications

RNA isolation, complementary DNA (cDNA) synthesis, and
transcript measurements
Total RNA was isolated from tissues using TRIzol reagent
(15596018; ThermoFisher). cDNA was synthesized from
1 µg of total RNA using the High Capacity cDNA Reverse
Transcription Kit (4368813; Applied Biosystems, Foster
City, California, USA). Quantitative PCR (qPCR) was
performed with a reaction mixture (20 µL) containing
cDNA diluted five times with water and PowerSYBR
Green PCR Master Mix (4367659; Applied Biosystems)
using specific primer (250 nM) sequences (online supplementary table 1). Amplification and florescence detection were carried out using an ABI 7500 Real Time PCR
system (Applied Biosystems) for 40 cycles (95°C, 10 min;
92°C, 15 s; 60°C, 1 min; 95°C, 15 s; 60°C, 15 s; 95°C, 15 s).
Relative transcript expression was calculated by ΔΔCt
method and normalized to 18S rRNA.
RNA sequencing (RNA-seq)
Transcript profiles for gd 13.5 rat junctional zone tissue
isolated from control and hyperglycemic pregnancies
were generated by RNA-seq as previously described.19
cDNA libraries from total RNA samples were prepared
with Illumina TruSeq RNA preparation kits (Illumina,
San Diego, California, USA). Barcoded cDNA libraries
were multiplexed and sequenced with a HiSeq2000
DNA sequencer (100 bp paired-
end reads) using a
TruSeq 200-
cycle SBS kit (Illumina) at the KUMC
Genome Sequencing Facility. Reads from *.fastq files
were mapped to the rat reference genome (Ensembl
Rnor_5.0.78) using CLC Genomics Workbench 12.0
(Qiagen, Redwood City, California, USA). mRNA abundance was expressed in reads per kilobase of exon per
million reads mapped. A false discovery rate of 0.05 was
used as a cut-off for significant differential expression
(euglycemia vs hyperglycemia). Functional patterns of
transcript expression were analyzed using Ingenuity
Pathway Analysis (Qiagen).
Western blotting
Placental tissues were homogenized in radioimmunopreciptation assay lysis buffer (sc-
24948A; Santa
Cruz Biotechnology, Dallas, Texas, USA) supplemented with Halt Protease and phosphatase inhibitor
cocktail (78443; ThermoFisher). Protein concentrations were determined by the DC protein assay (Bio-
Rad, Hercules, California, USA). A total of 50 µg
of protein per reaction sample were separated on
4%–20% ExpressPlus PAGE Gels (M42012, M42015;
GenScript, Piscataway, New Jersey, USA), transferred to
BMJ Open Diab Res Care 2020;8:e001243. doi:10.1136/bmjdrc-2020-001243

polyvinylidene fluoride blotting membrane (10600023;
GE Healthcare). Following transfer, membranes were
blocked in 5% non-fat milk in Tris-buffered saline with
0.1% Tween 20, for non-specific binding and subsequently probed with specific primary antibodies to
prolactin family 3, subfamily d, member 4 (PRL3D4,
1:50020), PRL8A5 (1:50016), actin, beta (ACTB, 1:4000,
A1978; Sigma-Aldrich), and glyeraldehyde-3-phosphate
dehydrogenase (1:3000, ab9485; Abcam, Cambridge,
Massachusetts, USA). Immunoreactive proteins were
visualized by Luminata Crescendo Western HRP
substrate (WBLUR0500; Millipore, Billerica, Massachusetts, USA) according to the manufacturer’s protocol.
Statistical analysis
Statistical analyses were performed using GraphPad
Prism 8 software. Welch’s t-
tests, Brown-
Forsythe and
Welch analysis of variance (ANOVA) tests, and two-way
ANOVA tests were applied when appropriate. Data are
represented as mean±SD with the statistical significance
level set at p<0.05.
Data and resource availability
The datasets generated and analyzed during the current
study are available in the Gene Expression Omnibus
website (https://www.ncbi.nlm.nih.gov/geo/; accession
no GSE144276). All data generated and analyzed during
this study are included in the published article and the
online supplementary files. Resources generated and
analyzed during the current study are available from the
corresponding authors on reasonable request.
Results
Diabetes-induced placental malformation decreases
placental efficiency and fetal size
To determine the effect of diabetes on hemochorial placentation, pregnant rats were treated with
STZ beginning on gd 6.5 to induce hyperglycemia
i mplantation but prior to placental formation
post-
(figure 1A). This STZ model caused a decrease in
maternal body weight on gd 13.5 (p<0.05), which is
indicative of uncontrolled diabetes (online supplementary figure 1). There were no significant effects
of STZ-i nduced hyperglycemia on maternal pancreas,
liver, or spleen weights at gd 13.5 or gd 18.5 (online
supplementary figure 1). STZ-t reated rats had significantly elevated blood glucose levels compared with
vehicle control-treated rats on both gd 13.5 and gd
18.5, indicating that STZ was effectively disrupting
beta cell function (p<0.0001; figure 1B). Conceptus
viability was not significantly different between
vehicle control and STZ-
t reated rats on gd 18.5,
despite significantly increased blood glucose levels
(figure 1C). To assess the impact of hyperglycemia
on placentation and fetal growth, placental and fetal
weights were examined on gd 18.5, a developmental
state characterized by a fully mature placentation
site. Hyperglycemia was associated with significantly
3
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within the uterine mesometrial compartment containing
cytokeratin-
positive trophoblast cells. Junctional zone
thickness was estimated as the area intensely staining with
antibodies to pan-cytokeratin in placental cross sections.
All morphometric measurements were acquired from a
histological plane at the center of each placentation site
perpendicular to the fetal interface of the placenta.

Pathophysiology/Complications

increased placental weight (p<0.001) and significantly decreased fetal weight (p<0.0001; figure 1D).
Fetal to placental weight ratio, a measure of placental
efficiency, was significantly decreased in hyperglycemic rats compared with the euglycemic control
4

(p<0.0001; figure 1D). No significant sex differences
were observed in placental weight, fetal weight, or the
fetal to placental weight ratio (online supplementary
figure 2) on gd 18.5. Taken together, these results
suggest that exposure to STZ-i nduced hyperglycemia,
BMJ Open Diab Res Care 2020;8:e001243. doi:10.1136/bmjdrc-2020-001243
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Figure 1 Diabetes-induced placental malformation decreases placental efficiency. (A) Schematic depicting the experimental
design for streptozotocin (STZ) treatment of pregnant rats. Vehicle control solution (0.1 M citrate buffer, pH 4.2) or STZ
(45 mg/kg) was injected into pregnant rats on gestation day (gd) 6.5. Rats were subsequently sacrificed for tissue harvest on
gd 13.5 or 18.5. (B) Blood glucose was measured on gd 13.5 and 18.5. STZ treatment (gray) significantly increased blood
glucose levels compared with vehicle control-treated (black) animals (n=6 per group, p<0.0001). (C) The average number of
viable conceptuses was no different between euglycemic and hyperglycemic animals on gd 18.5 (n=6 per group, p>0.05).
(D) Placental and fetal weights (g) were measured at the time of sacrifice on gd 18.5. Hyperglycemia significantly increased
placental weight (n=15 per group; p<0.001), but significantly decreased fetal weight compared with euglycemia (n=15 per
group; p<0.0001). The ratio of fetal to placental weight (g), a measure of placental efficiency, was significantly decreased in
animals with hyperglycemia (n=15 per group; p<0.0001). (E) Placentation sites collected from euglycemic and hyperglycemic
pregnant dams on gd 18.5 were sectioned and stained with a cytokeratin-specific antibody (green) for immunohistochemical
analysis and visualization of trophoblast cells and placental compartments. (F) Junctional zone (JZ) and labyrinth zone (LZ)
areas (pixels) were quantified using ImageJ (National Institutes of Health). Placentae collected from dams with hyperglycemia
had significantly increased JZs (n=10 Eug, n=14 Hyp; p<0.001) and LZs (n=10 Eug, n=14 Hyp; p<0.0001) compared with
euglycemic rats.

Pathophysiology/Complications

Expanded junctional zone contributes to increased placental
size
To further identify the specific placental malformations
resulting from diabetes exposure, placentation sites
were harvested and their histological organization were
assessed using immunofluorescence staining with a pan-
cytokeratin antibody. The pan-cytokeratin antibody preferentially detects trophoblast cells within the junctional
zone of the placenta (figure 1E). In contrast, trophoblast-
associated cytokeratin expression in the labyrinth zone
is diminished relative to the junctional zone because
of its substantial mesenchymal cell content. Using this
immunohistochemical approach, junctional and labyrinth zone areas were quantified. Area quantification
confirmed that both junctional and labyrinth zones are
significantly expanded in placentas from hyperglycemic
pregnancies compared with euglycemic pregnancies
(p<0.001, p<0.0001; figure 1F). Expanded regions of
low cell density, corresponding to a greater number of
glycogen cells, fill the junctional zones of placentation
sites from hyperglycemic rats and contribute to the
observed increase in junctional zone area.

Diabetes alters junctional zone gene expression profiles
To gain insights into molecular mechanisms associated
with the expanded junctional zone of placentas from
dams with poorly controlled diabetes, we performed RNA-
seq to assess transcriptomic profiles from euglycemic and
hyperglycemic pregnant rats on gd 13.5 (n=4/group). By
gd 13.5, placental zonation is established, but infiltration
of invasive trophoblast cells into the uterine parenchyma
has yet to occur. Analysis of the RNA-seq data identified
89 significantly upregulated transcripts and 319 significantly downregulated transcripts in the hyperglycemic
group compared with the euglycemic group (figure 2A).
Pathway analysis encompassing all significantly altered
transcripts identified several cell processes implicated
in junctional zone changes in response to uncontrolled
diabetes. Inflammation, cell death, and glucose metabolism disorder were highly associated with the upregulated transcripts (figure 2A). Conversely, significantly
downregulated transcripts in the hyperglycemia group
included inflammatory response, cellular growth and
proliferation, macronutrient metabolism, cell signaling,
as well as cell survival and differentiation. Several significantly upregulated and downregulated genes were validated by reverse transcription quantitative polymerase
chain reaction (RT-qPCR) (figure 2B). Among the differentially expressed transcripts were two prolactin family

Figure 2 Diabetes exposure alters junctional zone gene expression. (A) Volcano plot depicting differential gene expression
identified by RNA sequencing analysis of junctional zones from euglycemic and hyperglycemic pregnant dams (n=4 per group).
Each dot represents one gene. The x-axis depicts logarithm to base 2 of the fold change (logFC). Significantly downregulated
(blue) and upregulated (red) genes are highlighted. Pie charts display the percentage of upregulated (top) or downregulated
(bottom) genes, identified by the RNA sequencing analysis, that contribute to the top gene ontology (GO) terms (GO: #)
identified by Biological Process analysis. (B) Levels of select transcripts were quantified by reverse transcription quantitative
polymerase chain reaction (RT-qPCR) to validate results obtained from RNA sequencing analysis. RT-qPCR validation
was performed on a number of transcripts (x-axes), which were significantly upregulated (left) or downregulated (right) in
junctional zones from animals with hyperglycemia (gray) compared with euglycemia (black; n=6 per group, *p<0.05, **p<0.01,
***p<0.001,****p<0.0001).
BMJ Open Diab Res Care 2020;8:e001243. doi:10.1136/bmjdrc-2020-001243
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a hallmark of poorly controlled diabetes, led to
placental deficits and, as a result, diminished fetal
size.
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Elevated glucose disrupts rat TS cell differentiation
One of the primary manifestations of diabetes, and
a phenomenon we observe in our rat model, is hyperglycemia. To determine if elevated glucose impacts TS
cell behavior, we cultured rat TS cells in 5 mM glucose
(approximating a euglycemic state) or 25 mM glucose
(approximating a hyperglycemic state) and assessed
the ability of TS cells to undergo cell differentiation,
focusing on junctional zone transcripts affected by hyperglycemia in vivo (figure 2B). Transcript levels were used
to determine the extent of differentiation throughout a
16-day differentiation time course. In 5 mM glucose, rat
TS cells begin to induce expression of genes indicative
of trophoblast cell differentiation (Alox15, Prl3d4, Tpbpa,
Taf7l) with increasing transcript levels observed until day
16 (figure 3A). Under TS cell-differentiating conditions
in the presence of elevated glucose (25 mM), Alox15 is
induced to a significantly greater extent on days 12 and 16
of differentiation compared with culture in 5 mM glucose
exposure (figure 3A). In contrast, rat TS cells differentiated in 25 mM glucose exhibit significantly decreased
expression of other differentiation-associated transcripts
at day 16 of culture, including Prl3d4, Plac1, Tpbpa, Taf71,
and Prl8a5 (figure 3A). A similar inhibition of PRL8A5
and PRL3D4 protein expression was also observed in
25 mM glucose-
exposed TS cells (figure 3B,C; online
supplementary figure 4). Overall, the results indicate
that elevated glucose impairs TS cell differentiation and
parallel in vivo placental responses to hyperglycemia.
Diabetes impairs intrauterine trophoblast invasion
The junctional zone is prominently altered in our rat
model of poorly controlled diabetes (figures 1 and 2)
and represents the site of progenitors for invasive trophoblast lineage development within the rat placenta.6 21
Therefore, we sought to determine whether hyperglycemia impacts development of the invasive trophoblast
lineage in vivo. To assess this, we quantified the depth
and extent of cytokeratin-positive trophoblast cell invasion into the uterus and measured transcript levels of
invasive trophoblast-
specific markers (Prl5a1, Prl7b1,
Plac1) in dissected metrial glands, the site of intrauterine
trophoblast cell invasion.
6

Quantitation of the depth of trophoblast invasion by
cytokeratin staining in euglycemic and hyperglycemic
pregnant rats was assessed on gd 18.5. Endovascular
trophoblast invasion depth was similar in euglycemic
and hyperglycemic pregnant rats (figure 4B). However,
interstitial trophoblast invasion was almost completely
absent on gd 18.5 in hyperglycemic rats compared with
euglycemic rats (figure 4A). Total area of trophoblast
invasion, including endovascular and interstitial, was
decreased in hyperglycemic compared with euglycemic
pregnant rats (figure 4C). Prl5a1 and Prl7b1 are specific
markers of intrauterine invasive trophoblast cells,22 23 and
Plac1 has recently been implicated as an intrinsic regulator of the invasive trophoblast lineage.24 Prl5a1, Prl7b1,
and Plac1 transcript levels were significantly decreased
within the uterine–placental interface of hyperglycemic
versus euglycemic pregnancies (figure 4D). Collectively,
the results indicate that hyperglycemia adversely affects
development of the invasive trophoblast lineage.
Hyperglycemia and placenta plasticity
A fundamental property of the placenta is its plasticity.25
The placenta possesses the ability to adapt to a wide
range of environmental challenges that could threaten
pregnancy.6 25 Adjustments in trophoblast–uterine spiral
artery interactions are a key component of placental
adaptations to environmental stressors.4 26 Hypoxia has
proven to be an effective tool to elicit adaptations in the
development of the maternal–fetal interface.17 Since
hyperglycemia affected both junctional zone and invasive
trophoblast cell lineage development, we sought to determine the impact of hyperglycemia on hypoxia-induced
placental plasticity.
We used an experimental paradigm of hypoxia exposure in the pregnant rat proven to activate endovascular
trophoblast invasion and trophoblast-
guided uterine
spiral artery remodeling.17 Euglycemic and hyperglycemic rats were exposed to ambient conditions (~21%
oxygen) or hypoxia (10.5% oxygen) beginning on gd
6.5 and sacrificed on gd 13.5 (figure 5A). The extent
of STZ-induced hyperglycemia was similar in ambient
and hypoxia exposed pregnant rats (figure 5B).
Hypoxia exposure significantly decreased uterine +
conceptus weight in hyperglycemic compared with euglycemic pregnant rats at gd 9.5 (p<0.01; figure 5A) but did
not adversely affect conceptus viability. Conceptuses from
euglycemic pregnant rats exposed to ambient or hypoxic
conditions and conceptuses from hyperglycemic pregnant rats exposed to ambient conditions survived to gd
9.5 (figure 5D). However, by gd 13.5 all hyperglycemic
rats exposed to hypoxia showed complete pregnancy loss
(p<0.0001; figure 5E). These findings prompted examination of conceptus development in each group at an
earlier stage of gestation (gd 9.5). Histological analysis
of gd 9.5 conceptuses demonstrated that development of
the primordial placenta, referred to as the ectoplacental
cone, was adversely affected in hyperglycemic pregnancies exposed to hypoxia (figure 5F), which was verified
BMJ Open Diab Res Care 2020;8:e001243. doi:10.1136/bmjdrc-2020-001243
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members, Prl3d4 and Prl8a5, which are known markers
of junctional zone development.16 20 PRL3D4 protein
levels were quantified in junctional zone tissue collected
from euglycemic and hyperglycemic pregnancies on gd
13.5 and gd 18.5 by western blotting. PRL3D4 was significantly decreased in junctional zone tissues from hyperglycemic pregnancies at both gd 13.5 and 18.5 (gd 13.5,
p<0.0001, gd 18.5, p<0.01; online supplementary figure
3). Diminished PRL3D4 expression was also observed
within junctional zone compartments of placentation site
cross sections from hyperglycemic pregnancies (online
supplementary figure 3). Overall, the findings indicate
that poorly controlled diabetes induces dysregulation of
junctional zone development.

Pathophysiology/Complications

by the quantification of ectoplacental cone surface area
(p<0.0001; figure 5G) and diminished proliferation,
as measured by phosphohistone H3 immunoreactivity
(p<0.0001; figure 5H). Thus, hyperglycemia adversely
affects placental adaptations to hypoxia.
High glucose blunts TS cell responses to low oxygen
To determine whether the interaction of hyperglycemia
and hypoxia was directly altering trophoblast lineage
development, we investigated the impact of glucose on
TS cell responses to low oxygen in vitro. Transcript levels
of known TS cell hypoxia-responsive genes, including
IL33 and CD200, were measured by RT-qPCR.27 IL33 and
BMJ Open Diab Res Care 2020;8:e001243. doi:10.1136/bmjdrc-2020-001243

CD200 transcript concentrations were similar in TS cells
cultured in 5 mM or 25 mM glucose exposed to ambient
conditions (p<0.01; online supplementary figure 5). In
contrast, exposure to low oxygen significantly induced
expression of IL33 and CD200 in 5 mM glucose (p<0.01)
but IL33 and CD200 were not induced by hypoxia in
25 mM glucose (p<0.01). We also examined the interactive effects of glucose and hypoxia on TS cell number.
TS cell viability was not altered by the culture conditions (figure 5I); however, low oxygen stimulated TS cell
proliferation in 5 mM glucose, but not in 25 mM glucose
(p<0.0001; figure 5I). These in vitro results support the
7
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Figure 3 High glucose modulates rat trophoblast stem cell (TS) differentiation. (A) Rat TS cells were cultured in differentiation
medium containing 5 mM glucose (black) or 25 mM glucose (gray) for 16 days. RNA was isolated from both treatment groups
at five time points (days 0, 4, 8, 12, and 16). Significant differences are denoted by asterisks (n=6 per group; *p<0.05, **p<0.01,
****p<0.0001). Western blot depicting PRL8A5 (B) protein levels in rat TS cells cultured in differentiation medium containing
5 mM glucose (black) or 25 mM glucose (gray). Protein was collected from both treatment groups at five time points (days 0,
4, 8, 12, and 16). PRL8A5 protein levels were quantified with ImageJ (National Institutes of Health), normalized to beta actin
(ACTIN), and graphed as “Relative Protein Abundance” (y-axis; n=5 per group). (C) Immunocytochemical analysis of PRL8A5
(red) expression in rat TS cells cultured in differentiation medium containing 5 mM glucose or 25 mM glucose for 16 days.
4’,6-diamidino-2-phenylindole (DAPI, blue) marks cell nuclei.
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in vivo observations that diabetes (hyperglycemia) alters
placental cell plasticity through, at least in part, direct
actions on trophoblast cell development.
Discussion
Animal models have been effectively used to investigate
diabetes and pregnancy.28 In this study, we examined
the impact of poorly controlled diabetes on placental
and fetal development in the rat. We provide evidence
that placental development in a hyperglycemic state is
not optimal. Hyperglycemia leads to the formation of
an abnormally large, inefficient placenta that adversely
8

affects fetal growth and that does not adapt well to an
adverse maternal environment. Our results suggest that
some of the effects of hyperglycemia on placentation are
due to the direct actions of high glucose on trophoblast
cell behavior.
In this report, we have not attempted to mimic a specific
human syndrome or disease state with the rat. Fundamental differences between rat and human pregnancy
render such a task highly problematic. Placentation-
related events that transpire during rodent gestation best
equate to physiological changes that occur during the
first trimester of human pregnancy.29 From a superficial
BMJ Open Diab Res Care 2020;8:e001243. doi:10.1136/bmjdrc-2020-001243
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Figure 4 Diabetes impairs uterine trophoblast invasion and spiral artery remodeling. (A) Placentation sites collected from
euglycemic (Eug) and hyperglycemic (Hyp) rats on gestation day (gd) 18.5 were sectioned and stained with a cytokeratin-
specific antibody (green) for immunohistochemical analysis and visualization of trophoblast cells and placental compartments.
Brightly labeled, cytokeratin-positive trophoblast cells invade interstitially and endovascularly into the metrial gland
compartment. Images were acquired with a 10× objective. The scale bars represent 250 µm. (B) Depth of intrauterine
trophoblast cell invasion was quantified in ImageJ (National Institutes of Health (NIH) as an invasion index, or the distance of
distal-most endovascular cytokeratin-positive cell relative to the trophoblast giant cell layer of the chorioallantoic placenta.
Invasion depth was similar between Eug and Hyp pregnant rats (n=10 Eug, n=9 Hyp; p>0.05). (C) Total area of trophoblast
invasion, including endovascular and interstitial, was quantified in ImageJ (NIH). Hyp significantly reduced interstitial, but not
endovascular, trophoblast invasion compared with Eug (n=10 Eug, n=9 Hyp; p<0.001). (D) RNA was isolated from uterine–
placental interface tissue dissected from Eug and Hyp pregnant dams on gd 18.5. Prl5a1, Prl7b1, and Plac1 transcripts were
significantly downregulated in the uterine–placental interface collected from Hyp animals (gray) compared with Eug animals
(black; n=6 per group, *p<0.05, **p<0.01).
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perspective, placentation appears to be different in the
rat and human; however, this view is biased by the use
of distinct, species-
specific nomenclature. In fact, rat
and human placentas are highly conserved.21 25 30 Both
species possess hemochorial placentas that perform the
same critical tasks. Central to those tasks are specialized
trophoblast cells that transform the uterine environment,
including restructuring the uterine spiral arteries, to
regulate delivery of maternal nutrients to the developing
fetus.25 30 Although the hyperglycemia we observe with
our model of STZ-induced beta cell damage may best
reflect poorly controlled type 1 diabetes in pregnancy,
the goal of the experimentation outlined in this report
was to gain broader insights into the impact of glucose
dysregulation on the morphogenesis of the placenta.
Disruptions in placental structure are a common
feature of hyperglycemia.28 31 Our observations of
BMJ Open Diab Res Care 2020;8:e001243. doi:10.1136/bmjdrc-2020-001243

placentomegaly are consistent with earlier reports examining the effects of diabetes mellitus on placental development in the mouse and rat.32–35 An expansion of glycogen
cells within the junctional zone compartment has been
a common finding.36 37 Diabetes in humans is associated
with alterations in placental surface area, volume, intervillous space, terminal villi, syncytiotrophoblast, fibrinoid
areas, and glycogen deposits.31
A key element of human placentation is the entry
of trophoblast cells into the uterus where they restructure the uterine parenchyma, including remodeling of
uterine spiral arteries.4 5 25 This form of deep placentation
is also observed in the rat.21 22 Two invasive trophoblast
cell populations are evident. Interstitial invasive trophoblast cells are situated between the uterine vasculature,
whereas endovascular invasive trophoblast cells replace
the endothelium of the uterine spiral arterioles.4 5 25 In
9
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Figure 5 Hyperglycemia diminishes conceptus viability and ectoplacental cone development (EPC) in pregnant rats exposed
to hypoxia. (A) Schematic depicting the experimental design for streptozotocin (STZ) treatment and hypoxia exposure of
pregnant rats. Half of the rats were maintained in ambient air housing and the other half were housed in a gas-regulated
chamber to mimic hypoxia (10.5% (vol/vol) oxygen) until sacrifice on gestation day (gd) 9.5 or 13.5 for tissue harvest.
Photomicrographs of whole uteri collected from euglycemia (Eug) and hyperglycemia (Hyp) animals housed in ambient air or
hypoxia. (B) Glucose was measured on gd 13.5 in rats housed in ambient air and hypoxia. Hyp (gray) possessed significantly
increased blood glucose levels compared with Eug (black) animals in both ambient air and hypoxia (n=6 for all groups except
n=8 for Hyp in hypoxia, p<0.0001). (C) Uterine weight was significantly reduced in Hyp animals compared with Eug animals
when exposed to hypoxia n=5 for ambient and n=6 for hypoxia, p<0.01). (D) The average number of viable conceptuses was
not different between Eug (black) and Hyp (gray) animals housed in ambient air or hypoxia on gd 9.5 (n=5 for ambient and n=6
for hypoxia, p>0.05). (E) Viable conceptuses were not recovered in Hyp animals housed in hypoxia on gd 13.5, resulting in a
significant difference between treatment groups (n=6 per group, p<0.0001). (F) Placentation sites were collected on gd 9.5,
sectioned, and stained for cytokeratin (green) and 4’,6-diamidino-2-phenylindole (DAPI, blue) from Eug and Hyp rats housed
in ambient air or hypoxia (10.5% O2). (G) EPC size, quantified as relative area of cytokeratin-positive cells, is significantly
decreased in Hyp animals (gray) compared with Eug animals (black) (n=13 per group, p<0.0001). (H) Hyp significantly
decreased EPC cell proliferation, which was measured as the number of phospho-histone H3 positive cells (n=6 per group,
p<0.0001). (I) Rat trophoblast stem cells were cultured in medium containing 5 mM glucose (black) or 25 mM glucose (gray)
and were maintained in either ambient air or exposed to low oxygen (1.5% O2) for 24 hours and the number of viable cells
quantified. Significant differences are denoted by asterisks (n=6 per group, p<0.0001).
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low oxygen tensions and increased risks for pregnancy
complications.52 The combination of high altitude and
diabetes may be particularly problematic to the development of an effective hemochorial placenta.
In summary, our data generated using an in vivo STZ
model of diabetes and in vitro analyses of TS cells support
the hypothesis that exposure to hyperglycemia during
gestation induces placental alterations that result in
impaired fetal outcomes. The initiation of hyperglycemia
post-embryo implantation was a key element of our experimental design and distinct from other animal models
of diabetes.28 Our findings strengthen earlier observations that intrauterine exposure to hyperglycemia alters
structural formation and glycogen cell accumulation
within the placenta. New insights into the impairment of
trophoblast differentiation and invasion in placentation
sites from dams with hyperglycemia highlights a potential
mechanism by which fetal growth restriction may occur
in this model. We also found that placentas from hyperglycemic pregnancies lacked the requisite plasticity to
adapt to the stress of hypoxia exposure and led to pregnancy loss. These findings reinforce the damaging effects
of poorly controlled diabetes on placental formation and
pregnancy outcomes as well as the experimental value of
the rat model in the investigation of hemochorial placentation and critical events regulating trophoblast invasion
and spiral artery remodeling.
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our experimentation, we observed that hyperglycemia
preferentially led to disruptions in the interstitial invasive trophoblast population. Impairments in intrauterine
trophoblast cell invasion have also been observed in the
biobreeding diabetes-prone rat model.38 There is also
some indication that trophoblast cell invasion is adversely
affected in humans with diabetes.39 40 Specific mechanisms underlying invasive trophoblast cell reorganization of the uterine parenchyma is not well appreciated.
Furthermore, we know little of how hyperglycemia affects
differentiation of the invasive trophoblast cell lineage.
Some insights into the effects of hyperglycemia on
placentation may be gleaned from the transcript profile
of junctional zone placental tissue from euglycemic and
hyperglycemic rat pregnancies. In addition to the dysregulation of species-
specific members of the prolactin
family (Prl3d4, Prl8a5, Prl8a9), transcripts from the
pregnancy-specific glycoprotein family (Cgm4), and the
cathepsin family (Cts7), were also identified as dysregulated in response to hyperglycemia. Downregulated transcripts, such as Taf7l, Pappa2, and Plac1, could contribute
to hyperglycemia-induced placental dysmorphogenesis.
Taf7l encodes a member of a family of proteins that
associate with the TATA-
binding protein (TBP) and
is essential for TBP binding to the TATA element and
transcription.41 TAF7L has been implicated in sperm
development and the regulation of adipocyte differentiation,42 43 but not placentation. Pappa2 encodes a protease
targeting insulin-
like growth factor (IGF)-
binding
proteins,44 which modulate the activity of IGFs,45 known
regulators of placental growth.46 However, disruption
of Pappa2 in the mouse has only subtle effects on male
reproduction and modest effects on postnatal growth
with no reported adverse effects on placental development.47 48 In contrast, placenta specific 1 (Plac1), a highly
conserved X-linked gene, possesses pronounced effects
on placentation.49 50 Targeted disruption of Plac1 in the
mouse leads to placentomegaly, including an expanded
junctional zone.49 50 Downregulation of Plac1 expression in the placenta associated with hyperglycemia fits
well with the phenotype of the Plac1 null mouse. Thus,
PLAC1 represents a candidate mediator of the effects of
hyperglycemia on placentation.
A healthy placenta exhibits plasticity and can adapt to
a range of environmental challenges.6 25 Hypoxia is an
environmental challenge that can elicit placental adaptations, including the stimulation of trophoblast invasion and spiral artery remodeling.17 Hypoxia is also a
physiological regulator of placentation26 and has been
identified as a key regulator of invasive/extravillous
trophoblast cell differentiation.18 27 51 Dual exposure to
hyperglycemia and hypoxia in the rat was not compatible with pregnancy. Pregnancies were terminated due to
growth arrest at the ectoplacental cone stage of placentation. Cellular responses to low oxygen were blunted
when TS cells were cultured in high glucose implicating
direct interactive effects of oxygen tension and glucose
on trophoblast cells. High altitude is associated with
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